Childhood-onset Schizophrenia: What Do We Really Know?

Overview

Journal Health Psychol Behav Med

Date 2015 Mar 10

PMID 25750815

Citations 9

Authors

Jennifer Bartlett

Affiliations

Soon will be listed here.

Abstract

Childhood-onset schizophrenia (COS) is a rare, chronic mental illness that is diagnosed in children prior to the age of 13. COS is a controversial diagnosis among clinicians and can be very difficult to diagnose for a number of reasons. Schizophrenia is a psychotic disorder characterized by hallucinations, delusions, flat affect, limited motivation and anhedonia. The psychotic nature of this disorder is quite disruptive to the child's emotional regulation, behavioural control and can reduce the child's ability to perform daily tasks that are crucial to adaptive functioning. Prior to the onset of schizophrenia, children often develop premorbid abnormalities, which are disturbances to a child's functioning that may serve as warning signs. These disturbances can manifest in a variety of behavioural ways and may include introversion, depression, aggression, suicidal ideation and manic-like behaviours. This article will review the clinical presentation of schizophrenia in children and examine the existing knowledge around aetiology, treatment approaches, assessment techniques and differential diagnostic considerations. Gaps in the literature are identified and directions for future research are discussed.

Citing Articles

The genetic basis of onset age in schizophrenia: evidence and models.

Zhan N, Sham P, So H, Lui S Front Genet. 2023; 14:1163361.

PMID: 37441552 PMC: 10333597. DOI: 10.3389/fgene.2023.1163361.

The Triad of Childhood-Onset Schizophrenia, Autism Spectrum Disorder, and Catatonia: A Case Report.

Leslie A, OSullivan M Schizophr Bull. 2023; 49(2):239-243.

PMID: 36719136 PMC: 10016408. DOI: 10.1093/schbul/sbac200.

Shared and distinct white matter abnormalities in adolescent-onset schizophrenia and adolescent-onset psychotic bipolar disorder.

Seitz-Holland J, Nagele F, Kubicki M, Pasternak O, Cho K, Hough M Psychol Med. 2022; 53(10):4707-4719.

PMID: 35796024 PMC: 11119277. DOI: 10.1017/S003329172200160X.

Letters to the Editor / Author's reply.

Ozdemir M, Ilgin C, Karavus M, Hidiroglu S, Luleci N, Ay P North Clin Istanb. 2022; 9(1):92.

PMID: 35340310 PMC: 8889208. DOI: 10.14744/nci.2022.98958.

Recognizing Psychosis in Autism Spectrum Disorder.

Ribolsi M, Fiori Nastro F, Pelle M, Medici C, Sacchetto S, Lisi G Front Psychiatry. 2022; 13:768586.

PMID: 35295770 PMC: 8918655. DOI: 10.3389/fpsyt.2022.768586.

References

Findling R, Johnson J, McClellan J, Frazier J, Vitiello B, Hamer R . Double-blind maintenance safety and effectiveness findings from the Treatment of Early-Onset Schizophrenia Spectrum (TEOSS) study. J Am Acad Child Adolesc Psychiatry. 2010; 49(6):583-94. PMC: 2882800. DOI: 10.1016/j.jaac.2010.03.013. View

Taylor E . Advances in the diagnosis and treatment of children with serious mental illness. Child Welfare. 1998; 77(3):311-32. View

. Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature. 2008; 455(7210):237-41. PMC: 3912847. DOI: 10.1038/nature07239. View

Shapiro D, Marenco S, Spoor E, Egan M, Weinberger D, Gold J . The Premorbid Adjustment Scale as a measure of developmental compromise in patients with schizophrenia and their healthy siblings. Schizophr Res. 2009; 112(1-3):136-42. PMC: 2702694. DOI: 10.1016/j.schres.2009.04.007. View

Zammit S, Allebeck P, Dalman C, Lundberg I, Hemmingson T, Owen M . Paternal age and risk for schizophrenia. Br J Psychiatry. 2003; 183:405-8. DOI: 10.1192/bjp.183.5.405. View

Brill N, Reichenberg A, Weiser M, Rabinowitz J . Validity of the premorbid adjustment scale. Schizophr Bull. 2007; 34(5):981-3. PMC: 2632481. DOI: 10.1093/schbul/sbm128. View

Egeland J . Frequency of attention deficit in first-episode schizophrenia compared to ADHD. Appl Neuropsychol. 2010; 17(2):125-34. DOI: 10.1080/09084280903297859. View

Pavuluri M, Herbener E, Sweeney J . Psychotic symptoms in pediatric bipolar disorder. J Affect Disord. 2004; 80(1):19-28. DOI: 10.1016/S0165-0327(03)00053-3. View

Kempf L, Hussain N, Potash J . Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: trouble at the borders. Int Rev Psychiatry. 2005; 17(1):9-19. DOI: 10.1080/09540260500064959. View

10.

Ross R, Heinlein S, Tregellas H . High rates of comorbidity are found in childhood-onset schizophrenia. Schizophr Res. 2006; 88(1-3):90-5. DOI: 10.1016/j.schres.2006.07.006. View

11.

Gallagher 3rd B, Jones B . Childhood stressors and symptoms of schizophrenia. Clin Schizophr Relat Psychoses. 2013; 7(3):124-30. DOI: 10.3371/CSRP.GAJO.020113. View

12.

Moller H . Bipolar disorder and schizophrenia: distinct illnesses or a continuum?. J Clin Psychiatry. 2003; 64 Suppl 6:23-7; discussion 28. View

13.

Maher K, Tan M, Tossell J, Weisinger B, Gochman P, Miller R . Risk factors for neutropenia in clozapine-treated children and adolescents with childhood-onset schizophrenia. J Child Adolesc Psychopharmacol. 2013; 23(2):110-6. PMC: 3608018. DOI: 10.1089/cap.2011.0136. View

14.

Maloney A, Yakutis L, Frazier J . Empirical evidence for psychopharmacologic treatment in early-onset psychosis and schizophrenia. Child Adolesc Psychiatr Clin N Am. 2012; 21(4):885-909. DOI: 10.1016/j.chc.2012.07.011. View

15.

Gentile S . Clinical usefulness of second-generation antipsychotics in treating children and adolescents diagnosed with bipolar or schizophrenic disorders. Paediatr Drugs. 2011; 13(5):291-302. DOI: 10.2165/11591250-000000000-00000. View

16.

Shaw P, Sporn A, Gogtay N, Overman G, Greenstein D, Gochman P . Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison. Arch Gen Psychiatry. 2006; 63(7):721-30. DOI: 10.1001/archpsyc.63.7.721. View

17.

Remschmidt H, Martin M, Fleischhaker C, Theisen F, Hennighausen K, Gutenbrunner C . Forty-two-years later: the outcome of childhood-onset schizophrenia. J Neural Transm (Vienna). 2006; 114(4):505-12. DOI: 10.1007/s00702-006-0553-z. View

18.

Margari F, Petruzzelli M, Lecce P, Todarello O, De Giacomo A, Lucarelli E . Familial liability, obstetric complications and childhood development abnormalities in early onset schizophrenia: a case control study. BMC Psychiatry. 2011; 11:60. PMC: 3090339. DOI: 10.1186/1471-244X-11-60. View

19.

Armenteros J, Davies M . Antipsychotics in early onset Schizophrenia: Systematic review and meta-analysis. Eur Child Adolesc Psychiatry. 2006; 15(3):141-8. DOI: 10.1007/s00787-005-0515-2. View

20.

Lauth B, Arnkelsson G, Magnusson P, Skarphedinsson G, Ferrari P, Petursson H . Validity of K-SADS-PL (Schedule for Affective Disorders and Schizophrenia for School-Age Children--Present and Lifetime Version) depression diagnoses in an adolescent clinical population. Nord J Psychiatry. 2010; 64(6):409-20. DOI: 10.3109/08039481003777484. View